SCMP up +11.04% percent Today $SCMP High is at 11.75 and

New Post Public Reply Private Reply Replies (0) Message Board

Nov 13, 2014 at 12:14 PM

SCMP up +11.04% percent Today $SCMP High is at 11.75 and the Low 10.54 with current volume of 153,337.

Recent News posted below.

Sucampo Pharmaceuticals SCMP other info.
http://investorshangout.com/Sucampo-Pharmaceu...CMP-55384/

SCMP Sucampo Pharmaceuticals Recent Headline News

Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 49 mins ago
Sucampo Pharmaceuticals (SCMP) was a big mover last session, with shares rising over 7% on the day.
LCI: 49.67 (-0.06), SHPG: 201.99 (+1.48), SCMP: 11.21 (+0.79), CEMP: 14.40 (+0.23)

R-Tech Ueno: Lawsuit Claiming Infringement of AMITIZA(R) Capsules Patents
Business Wire - Wed Nov 12, 7:57PM CST
R-Tech Ueno (JASDAQ:4573):
SCMP: 11.21 (+0.79)

Zacks' Bull Of The Day: Sucampo Pharma
Zacks Investment Research - Seeking Alpha - Wed Nov 12, 6:19PM CST
Sucampo Pharmaceuticals Inc. (NASDAQ: SCMP ) recently reported Q3 earnings data which topped both the Zacks Earnings and Revenue estimates. The main driver behind the beats was the strong sales growth of their signature drug Amitiza in both the U.S....
SCMP: 11.21 (+0.79)

Sucampo Files Patent Infringement Lawsuit Against Dr. Reddy's
GlobeNewswire - Wed Nov 12, 4:31PM CST
Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd., Takeda Pharmaceutical Company Limited (Takeda), and certain affiliates of Takeda have filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc. (collectively, Dr. Reddy's) related to an Abbreviated New Drug Application (ANDA) that Dr. Reddy's filed with the U.S. Food and Drug Administration (FDA) to market, sell and use a generic version of the 8 mcg and 24 mcg AMITIZA (lubiprostone) soft gelatin capsule products. The lawsuit claims infringement of 7 patents that are listed in the FDA's Orange Book, with the latest expiring in 2027.
SCMP: 11.21 (+0.79)

ANI Pharma (ANIP) & Sucampo Pharma (SCMP): Top Momentum Stocks to Add to Your Portfolio - Video Blog
David Bartosiak - Zacks Investment Research - Wed Nov 12, 1:59PM CST
ANI Pharma (ANIP) & Sucampo Pharma (SCMP), this week's top momentum stocks are discussed by Momentum Strategist David Bartosiak.
ANIP: 51.82 (-0.88), SCMP: 11.21 (+0.79)

Sucampo Pharmaceuticals, Titan International, Alibaba Group Holding, Costco Wholesale and Tesla Motors highlighted as Zacks Bull and Bear of the Day
PR Newswire - Wed Nov 12, 8:30AM CST
Zacks Equity Research highlights Sucampo Pharmaceuticals Inc. (Nasdaq:SCMP-Free Report) as the Bull of the Day and Titan International (NYSE:TWI-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onAlibaba Group Holding Limited (NYSE:BABA-Free Report), Costco Wholesale Corp. (Nasdaq:COST-Free Report) and Tesla Motors, Inc. (Nasdaq:TSLA-Free Report).
TSLA: 253.19 (+4.09), SCMP: 11.21 (+0.79), COST: 137.82 (+0.92), TWI: 10.23 (-0.44), BABA: 116.12 (-2.08)

Bull of the Day: Sucampo Pharma (SCMP) - Bull of the Day
Brian Hamilton - ZACKS - Wed Nov 12, 5:30AM CST
Bull of the Day: Sucampo Pharma (SCMP) - Bull of the Day
SCMP: 11.21 (+0.79)

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Stifel 2014 Healthcare Conference
GlobeNewswire - Tue Nov 11, 5:45AM CST
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Stifel 2014 Healthcare Conference taking place Tuesday, November 18, 2014 at 4:45 PM ET.
SCMP: 11.21 (+0.79)

Shares of SCMP Up 32.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 4:41PM CST
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on August 13th, 2014 at $6.98. In approximately 3 months, Sucampo Pharmaceuticals has returned 32.52% as of today's recent price of $9.25.
SCMP: 11.21 (+0.79)

Sucampo Pharmaceuticals (SCMP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:25AM CST

SCMP: 11.21 (+0.79)

Sucampo posts 3Q profit
Automated Insights - Thu Nov 06, 5:57AM CST
BETHESDA, Md. (AP) _ Sucampo Pharmaceuticals Inc. (SCMP) on Thursday reported net income of $1.5 million in its third quarter.
SCMP: 11.21 (+0.79)

Sucampo beats by $0.10, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 5:49AM CST

SCMP: 11.21 (+0.79)

Sucampo Announces Third Quarter 2014 Financial Results
GlobeNewswire - Thu Nov 06, 5:45AM CST
Strong Revenue and Sales Growth for AMITIZA
SCMP: 11.21 (+0.79)

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 Credit Suisse Global Healthcare Conference
GlobeNewswire - Wed Nov 05, 3:36PM CST
Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 2014 Credit Suisse Global Healthcare Conference taking place Wednesday, November 12, 2014 at 3:30 pm Mountain Time, or 5:30 pm Eastern Time.
SCMP: 11.21 (+0.79)

Reckitt Benckiser Pharmaceuticals Inc. Announces Appointment of Chief Financial Officer
PR Newswire - Tue Nov 04, 7:00AM CST
Reckitt Benckiser Pharmaceuticals Inc., a global specialty pharmaceutical company committed to pioneering innovative and accessible therapies for the chronic diseases of addiction and related mental health disorders, today announced the appointment of Cary J. Claiborne as Chief Financial Officer. Cary will lead the company's global financial and information technology operations, reporting to Chief Executive Officer Shaun Thaxter effective November 10, 2014.
SCMP: 11.21 (+0.79), OSIR: 13.41 (-0.09)

Uptrend Call Working As Sucampo Pharmaceuticals Stock Rises 26.4% (SCMP)
Comtex SmarTrend(R) - Fri Oct 31, 11:03AM CDT
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on August 13th, 2014 at $6.98. In approximately 3 months, Sucampo Pharmaceuticals has returned 26.36% as of today's recent price of $8.82.
SCMP: 11.21 (+0.79)

Sucampo Pharmaceuticals (SCMP) Upgraded From Hold to Buy
at The Street - Wed Oct 29, 8:59AM CDT
Sucampo Pharmaceuticals (SCMP) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B-.
SCMP: 11.21 (+0.79)

Sucampo Pharmaceuticals Up 20.8% Since SmarTrend Uptrend Call (SCMP)
Comtex SmarTrend(R) - Fri Oct 24, 9:47AM CDT
SmarTrend identified an Uptrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on August 13th, 2014 at $6.98. In approximately 2 months, Sucampo Pharmaceuticals has returned 20.77% as of today's recent price of $8.43.
SCMP: 11.21 (+0.79)

Sucampo Pharmaceuticals (SCMP) Stock Research Links

SCMP Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Tony Perkins' Church Tour amid Controversial Vote

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

NEXT Properties Exchange Offers: The Full Breakdown

What's the Deal with These Exchange Offers? You know, nothing says 'we're changing things up' like an exchange offer. So what did NEXT Properties do? Well, they laid down two offers for the books on their outstanding 6.950% and 6.390% senior notes, due in 2044 and 2050, respectively. These are getting swapped out for some fresh 7.731% senior sustainability-linked notes...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

CASEKOO's Spooky Collectibles: Postcards Meet Cases

Here we go with an unexpected twist in the phone accessory game. CASEKOO decided it's time to mix things up this Halloween with something as peculiar as it is intriguing: limited-edition Spooky Season Commemorative Postcards. A Spooky Strategy to Celebrate Ten Years Get this, folks—CASEKOO's looking to mark a decade in the business with more than just confetti and a...

TORRAS Stands Tall with iPhone 18 Pro Cases

By Riley Hayes Updated Oct 24, 2026 Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...